213 related articles for article (PubMed ID: 33706129)
1. Brivaracetam prevents astroglial l-glutamate release associated with hemichannel through modulation of synaptic vesicle protein.
Okada M; Fukuyama K; Shiroyama T; Ueda Y
Biomed Pharmacother; 2021 Jun; 138():111462. PubMed ID: 33706129
[TBL] [Abstract][Full Text] [Related]
2. Brivaracetam and Levetiracetam Suppress Astroglial L-Glutamate Release through Hemichannel via Inhibition of Synaptic Vesicle Protein.
Fukuyama K; Okada M
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562864
[TBL] [Abstract][Full Text] [Related]
3. Effects of Atypical Antipsychotics, Clozapine, Quetiapine and Brexpiprazole on Astroglial Transmission Associated with Connexin43.
Fukuyama K; Okada M
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070699
[TBL] [Abstract][Full Text] [Related]
4. Carbamazepine Attenuates Astroglial L-Glutamate Release Induced by Pro-Inflammatory Cytokines via Chronically Activation of Adenosine A
Okada M; Fukuyama K; Shiroyama T; Ueda Y
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31366130
[TBL] [Abstract][Full Text] [Related]
5. Effects of Carbamazepine, Lacosamide and Zonisamide on Gliotransmitter Release Associated with Activated Astroglial Hemichannels.
Fukuyama K; Ueda Y; Okada M
Pharmaceuticals (Basel); 2020 Jun; 13(6):. PubMed ID: 32516974
[TBL] [Abstract][Full Text] [Related]
6. Brivaracetam does not modulate ionotropic channels activated by glutamate, γ-aminobutyric acid, and glycine in hippocampal neurons.
Niespodziany I; Rigo JM; Moonen G; Matagne A; Klitgaard H; Wolff C
Epilepsia; 2017 Nov; 58(11):e157-e161. PubMed ID: 28850675
[TBL] [Abstract][Full Text] [Related]
7. Brivaracetam Prevents the Over-expression of Synaptic Vesicle Protein 2A and Rescues the Deficits of Hippocampal Long-term Potentiation In Vivo in Chronic Temporal Lobe Epilepsy Rats.
Ge YX; Lin YY; Bi QQ; Chen YJ
Curr Neurovasc Res; 2020; 17(4):354-360. PubMed ID: 32407277
[TBL] [Abstract][Full Text] [Related]
8. Binding characteristics of brivaracetam, a selective, high affinity SV2A ligand in rat, mouse and human brain: relationship to anti-convulsant properties.
Gillard M; Fuks B; Leclercq K; Matagne A
Eur J Pharmacol; 2011 Aug; 664(1-3):36-44. PubMed ID: 21575627
[TBL] [Abstract][Full Text] [Related]
9. Distinct Effects of Escitalopram and Vortioxetine on Astroglial L-Glutamate Release Associated with Connexin43.
Shiroyama T; Fukuyama K; Okada M
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576176
[TBL] [Abstract][Full Text] [Related]
10. Impact of 5-HT7 receptor inverse agonism of lurasidone on monoaminergic tripartite synaptic transmission and pathophysiology of lower risk of weight gain.
Fukuyama K; Motomura E; Shiroyama T; Okada M
Biomed Pharmacother; 2022 Apr; 148():112750. PubMed ID: 35219120
[TBL] [Abstract][Full Text] [Related]
11. Brivaracetam augments short-term depression and slows vesicle recycling.
Yang X; Bognar J; He T; Mohammed M; Niespodziany I; Wolff C; Esguerra M; Rothman SM; Dubinsky JM
Epilepsia; 2015 Dec; 56(12):1899-909. PubMed ID: 26515103
[TBL] [Abstract][Full Text] [Related]
12. Contribution of Astroglial Cx43 Hemichannels to the Modulation of Glutamatergic Currents by D-Serine in the Mouse Prefrontal Cortex.
Meunier C; Wang N; Yi C; Dallerac G; Ezan P; Koulakoff A; Leybaert L; Giaume C
J Neurosci; 2017 Sep; 37(37):9064-9075. PubMed ID: 28821660
[TBL] [Abstract][Full Text] [Related]
13. Interaction of Approved Drugs with Synaptic Vesicle Protein 2A.
Danish A; Namasivayam V; Schiedel AC; Müller CE
Arch Pharm (Weinheim); 2017 Apr; 350(3-4):. PubMed ID: 28220535
[TBL] [Abstract][Full Text] [Related]
14. Anti-convulsive and anti-epileptic properties of brivaracetam (ucb 34714), a high-affinity ligand for the synaptic vesicle protein, SV2A.
Matagne A; Margineanu DG; Kenda B; Michel P; Klitgaard H
Br J Pharmacol; 2008 Aug; 154(8):1662-71. PubMed ID: 18500360
[TBL] [Abstract][Full Text] [Related]
15. Further evidence for a differential interaction of brivaracetam and levetiracetam with the synaptic vesicle 2A protein.
Wood MD; Sands ZA; Vandenplas C; Gillard M
Epilepsia; 2018 Sep; 59(9):e147-e151. PubMed ID: 30144048
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological Profile of the Novel Antiepileptic Drug Candidate Padsevonil: Interactions with Synaptic Vesicle 2 Proteins and the GABA
Wood M; Daniels V; Provins L; Wolff C; Kaminski RM; Gillard M
J Pharmacol Exp Ther; 2020 Jan; 372(1):1-10. PubMed ID: 31619465
[TBL] [Abstract][Full Text] [Related]
17. Effects of an Atypical Antipsychotic, Zotepine, on Astroglial L-Glutamate Release through Hemichannels: Exploring the Mechanism of Mood-Stabilising Antipsychotic Actions and Antipsychotic-Induced Convulsion.
Fukuyama K; Okada M
Pharmaceuticals (Basel); 2021 Oct; 14(11):. PubMed ID: 34832898
[TBL] [Abstract][Full Text] [Related]
18. GABAergic Regulation of Astroglial Gliotransmission through Cx43 Hemichannels.
Jiménez-Dinamarca I; Reyes-Lizana R; Lemunao-Inostroza Y; Cárdenas K; Castro-Lazo R; Peña F; Lucero CM; Prieto-Villalobos J; Retamal MA; Orellana JA; Stehberg J
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362410
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of SV2A in hippocampal glutamatergic and GABAergic terminals during postnatal development.
Vanoye-Carlo A; Gómez-Lira G
Brain Res; 2019 Jul; 1715():73-83. PubMed ID: 30905653
[TBL] [Abstract][Full Text] [Related]
20. Brivaracetam: Rationale for discovery and preclinical profile of a selective SV2A ligand for epilepsy treatment.
Klitgaard H; Matagne A; Nicolas JM; Gillard M; Lamberty Y; De Ryck M; Kaminski RM; Leclercq K; Niespodziany I; Wolff C; Wood M; Hannestad J; Kervyn S; Kenda B
Epilepsia; 2016 Apr; 57(4):538-48. PubMed ID: 26920914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
